<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Iranian Journal of Endocrinology and Metabolism</title>
<title_fa>مجله‌ي غدد درون‌ريز و متابوليسم ايران</title_fa>
<short_title>Iranian Journal of Endocrinology and Metabolism</short_title>
<subject>Medical Sciences</subject>
<web_url>http://ijem.sbmu.ac.ir</web_url>
<journal_hbi_system_id>40</journal_hbi_system_id>
<journal_hbi_system_user>journal40</journal_hbi_system_user>
<journal_id_issn>1683-4844</journal_id_issn>
<journal_id_issn_online>1683-5476</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi></journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>fa</language>
<pubdate>
	<type>jalali</type>
	<year>1387</year>
	<month>4</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2008</year>
	<month>7</month>
	<day>1</day>
</pubdate>
<volume>10</volume>
<number>2</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>fa</language>
	<article_id_doi></article_id_doi>
	<title_fa>مقایسه بروز دیابت در تعریفهای متفاوت قند خون ناشتای مختل (مطالعه قند و لیپید تهران)</title_fa>
	<title>Comparison Between Diabetes Incidence using Different Cut Points of IFG: Tehran Lipid Glucose Study (TLGS)</title>
	<subject_fa>عمومى</subject_fa>
	<subject>General</subject>
	<content_type_fa>پژوهشی</content_type_fa>
	<content_type>Original</content_type>
	<abstract_fa></abstract_fa>
	<abstract>Introduction: In 2003, the American diabetes Association (ADA) recommended that the definition for a cut off of impaired fasting glucose (IFG) should be changed to 100- 125 mg/dl. This study has examined the effect of different cut points for IFG on diabetes incidence in Tehran's urban population. Material and methods: A total of 4929 (non-diabetic adults), aged 20-86 years, participants of the Tehran Lipid Glucose Study, were followed for diabetes incidence (based on FBS and glucose tolerance tests) for 3.5 years and were divided into various groups, normoglycemia &lt; 100, original IFG 110-125, added IFG 100-110 and new IFG100-125 mg/dL. Odds ratio for diabetic incidence after adjustment for confounding factors with logistic regression model was measured. Results: The mean ages were 42.9±13.7 (minimum 20 &amp; maximum 86 years old) 59.1% of participants were female (n= 2916). Prevalences of original IFG, added IFG and new IFG were 3.7% (n=183), 11.8% (n= 584), 15.5% (n= 767) respectively. At the end of study, 188 cases (3.8%) were diabetic. Incidence of diabetes in the normoglycemia, original IFG, added IFG and new IFG groups were 1.8% (n= 76), 26.2% (n= 48), 11% (n= 64), and 14.6% (n= 112) respectively. Odds ratios for diabetes incidence after adjustment for age/sex and confounding factors compared with normglycemia, diabetes incidence were 11.4 (7.4-17.6), 4.7 (3.3-6.8), 6.3 (4.5-8.5) for original IFG, added IFG, and new IFG respectively. Conclusion: The new IFG definition does not appear to have enhanced ability to predict diabetes incidence compared to the original IFG definition. </abstract>
	<keyword_fa>بروز، دیابت، IFG</keyword_fa>
	<keyword>Diabetes , Incidence, IFG</keyword>
	<start_page>133</start_page>
	<end_page>138</end_page>
	<web_url>http://ijem.sbmu.ac.ir/browse.php?a_code=A-10-81-41&amp;slc_lang=fa&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>L</first_name>
	<middle_name></middle_name>
	<last_name>Hajiabdolrasouli</last_name>
	<suffix></suffix>
	<first_name_fa>لادن</first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa>حاج عبدالرسولی</last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>400031947532846003476</code>
	<orcid>400031947532846003476</orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>F.</first_name>
	<middle_name></middle_name>
	<last_name>Hosseinpanah</last_name>
	<suffix></suffix>
	<first_name_fa>فرهاد</first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa>حسین پناه</last_name_fa>
	<suffix_fa></suffix_fa>
	<email>fhospanah@endocrine.ir</email>
	<code>400031947532846003477</code>
	<orcid>400031947532846003477</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name></first_name>
	<middle_name></middle_name>
	<last_name></last_name>
	<suffix></suffix>
	<first_name_fa>فریدون</first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa>عزیزی</last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>400031947532846003478</code>
	<orcid>400031947532846003478</orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
